Lonza tweaks E.coli expression system; denies takeover rumours
Lonza claims a new selection technology to its microbial protein expression system will improve yields and boost efficiency.
Archives for October 29, 2012
News from Lonza, DSM, Ark and AMRI
Outsourcing-pharma.com presents a roundup of contract manufacturing news with deals for Lonza, DSM and Ark Therapeutics and an expanded agreement with Shire for AMRI.
Novartis says banned flu jabs safe and that 'particles' common in vaccines
Novartis says two seasonal influenza vaccines temporarily banned by several European countries on quality concerns are safe.
New device should reduce risk posed by high-dose insulin
A new delivery device should reduce the risk posed by the availability of high-dose insulin in Europe say regulators, but vigilance is still needed.
Patheon to buy Banner Pharmacaps for $255m
Canadian CMO Patheon will buy softgel specialist Banner Pharmacaps, moving forward with its plan to build in the oral dose delivery sector.